Literature DB >> 33184589

Total and Formal Syntheses of Fostriecin.

Gao Dong1, Bohui Li2, George O'Doherty2.   

Abstract

Two formal syntheses and one total synthesis of fostriecin (1) have been achieved, as well as, the synthesis of its related congener dihydro-dephospho-fostriecin. All the routes use the Sharpless dihydroxylation to set the absolute stereochemistry at C-8/9 positions and a Leighton allylation to set the C-5 position of the natural product. In the formal syntheses a Noyori transfer hydrogenation of an ynone was used to set the C-11 position while the total synthesis employed a combination of asymmetric dihydroxylation and Pd-π-allyl reduction to set the C-11 position. Finally in the total synthesis, a trans-hydroboration of the C-12/13 alkyne was used in combination with a Suzuki cross coupling to establish the Z,Z,E-triene of fostriecin (1).

Entities:  

Year:  2020        PMID: 33184589      PMCID: PMC7654735          DOI: 10.1039/d0qo01121e

Source DB:  PubMed          Journal:  Org Chem Front        ISSN: 2052-4110            Impact factor:   5.281


  53 in total

1.  Formal catalytic asymmetric total synthesis of fostriecin.

Authors:  Kunihiko Fujii; Keisuke Maki; Motomu Kanai; Masakatsu Shibasaki
Journal:  Org Lett       Date:  2003-03-06       Impact factor: 6.005

2.  De novo synthesis of 2-substituted syn-1,3-diols via an iterative asymmetric hydration strategy.

Authors:  Md Moinuddin Ahmed; Matthew S Mortensen; George A O'Doherty
Journal:  J Org Chem       Date:  2006-09-29       Impact factor: 4.354

Review 3.  De novo synthesis of natural products via the asymmetric hydration of polyenes.

Authors:  Yanping Wang; Yalan Xing; Qi Zhang; George A O'Doherty
Journal:  Chem Commun (Camb)       Date:  2011-05-11       Impact factor: 6.222

4.  Inhibition of type II topoisomerase by fostriecin.

Authors:  T J Boritzki; T S Wolfard; J A Besserer; R C Jackson; D W Fry
Journal:  Biochem Pharmacol       Date:  1988-11-01       Impact factor: 5.858

5.  Asymmetric total synthesis of (+)-fostriecin.

Authors:  Y Krishna Reddy; J R Falck
Journal:  Org Lett       Date:  2002-03-21       Impact factor: 6.005

6.  Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters.

Authors:  C J Hastie; P T Cohen
Journal:  FEBS Lett       Date:  1998-07-24       Impact factor: 4.124

7.  The antitumor drug fostriecin induces vimentin hyperphosphorylation and intermediate filament reorganization.

Authors:  D T Ho; M Roberge
Journal:  Carcinogenesis       Date:  1996-05       Impact factor: 4.944

8.  In vitro activity of the novel antitumor antibiotic fostriecin (CI-920) in a human tumor cloning assay.

Authors:  W Scheithauer; D D Von Hoff; G M Clark; J L Shillis; E F Elslager
Journal:  Eur J Cancer Clin Oncol       Date:  1986-08

9.  Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.

Authors:  K Amrutha; Pandurangan Nanjan; Sanu K Shaji; Damu Sunilkumar; K Subhalakshmi; Lakshmi Rajakrishna; Asoke Banerji
Journal:  Bioorg Med Chem Lett       Date:  2014-08-14       Impact factor: 2.823

10.  Total synthesis of tetrahydrolipstatin and stereoisomers via a highly regio- and diastereoselective carbonylation of epoxyhomoallylic alcohols.

Authors:  Michael Mulzer; Brandon J Tiegs; Yanping Wang; Geoffrey W Coates; George A O'Doherty
Journal:  J Am Chem Soc       Date:  2014-07-18       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.